Works matching IS 03682811 AND DT 2017 AND VI 47 AND IP 7

Results: 15

Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 583, doi. 10.1093/jjco/hyx044

By:

Atsuo Takashima;
Sakura Iizumi;
Narikazu Boku

Publication type:

Article

The estimates of 5-year colorectal cancer prevalence in adult population in 2012.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 669, doi. 10.1093/jjco/hyx089

By:

Tomohiro Matsuda;
Ayako Okuyama

Publication type:

Article

Corrigendum.

Published in:: Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 668, doi. 10.1093/jjco/hyx078
Publication type:: Article

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 664, doi. 10.1093/jjco/hyx063

By:

Kenjiro Namikawa;
Arata Tsutsumida;
Tomonori Mizutani;
Taro Shibata;
Tatsuya Takenouchi;
Shusuke Yoshikawa;
Yoshio Kiyohara;
Hiroshi Uchi;
Masutaka Furue;
Dai Ogata;
Tetsuya Tsuchida;
Naoya Yamazaki

Publication type:

Article

Epidemiological analysis of childhood cancer in Japan based on population-based cancer registries, 1993-2009.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 660, doi. 10.1093/jjco/hyx041

By:

Hiroyuki Ishihara;
Yuko Ohno;
Makoto Fujii;
Junichi Hara;
Midori Soda

Publication type:

Article

Providing written information increases patient satisfaction: a web-based questionnaire survey of Japanese cancer survivors.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 611, doi. 10.1093/jjco/hyx043

By:

Hitomi Sakai;
Noriyuki Katsumata;
Miyako Takahashi

Publication type:

Article

Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 604, doi. 10.1093/jjco/hyx047

By:

Sho Takeshita;
Yukiharu Todo;
Yu Furuta;
Kazuhira Okamoto;
Shinichiro Minobe;
Katsushige Yamashiro;
Hidenori Kato

Publication type:

Article

Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial).

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 597, doi. 10.1093/jjco/hyx048

By:

Toshiki Mukai;
Keisuke Uehara;
Hidenari Goto;
Kazuhiro Hiramatsu;
Satoshi Kobayashi;
Eiji Sakamoto;
Atsuyuki Maeda;
Eiji Takeuchi;
Yoshito Okada;
Tomoki Ebata;
Masato Nagino

Publication type:

Article

Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 590, doi. 10.1093/jjco/hyw188

By:

Qian Huang;
Xin-Wen Zhang;
Yu-Shui Ma;
Gai-Xia Lu;
Ru-Ting Xie;
Hui-Qiong Yang;
Zhong-Wei Lv;
Xiao-Ming Zhong;
Tao Liu;
Shi-Xiong Huang;
Da Fu;
Chun Xie

Publication type:

Article

Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 652, doi. 10.1093/jjco/hyx051

By:

Junichi Inokuchi;
Masatoshi Eto;
Tomohiko Hara;
Hiroyuki Fujimoto;
Hiroyuki Nishiyama;
Jun Miyazaki;
Eiji Kikuchi;
Shiro Hinotsu;
Takuya Koie;
Chikara Ohyama

Publication type:

Article

Accessibility to surgical robot technology and prostate-cancer patient behavior for prostatectomy.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 647, doi. 10.1093/jjco/hyx052

By:

Toru Sugihara;
Hideo Yasunaga;
Hiroki Matsui;
Go Nagao;
Akira Ishikawa;
Tetsuya Fujimura;
Hiroshi Fukuhara;
Kiyohide Fushimi;
Makoto Ohori;
Yukio Homma

Publication type:

Article

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 639, doi. 10.1093/jjco/hyx049

By:

Yoshihiko Tomita;
Satoshi Fukasawa;
Nobuo Shinohara;
Hiroshi Kitamura;
Mototsugu Oya;
Masatoshi Eto;
Kazunari Tanabe;
Go Kimura;
Junji Yonese;
Masahiro Yao;
Robert J.;
Motzer;
Hirotsugu Uemura;
McHenry, M. Brent;
Berghorn, Elmer;
Seiichiro Ozono

Publication type:

Article

Surgical resection for clinical-Stage I radiological pure-solid lung cancer that met the current high risk criteria.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 630, doi. 10.1093/jjco/hyx054

By:

Aritoshi Hattori;
Takeshi Matsunaga;
Kazuya Takamochi;
Shiaki Oh;
Kenji Suzuki

Publication type:

Article

Efficacy and safety of osimertinib in a Japanese compassionate use program.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 625, doi. 10.1093/jjco/hyx050

By:

Yutaka Fujiwara;
Yasushi Goto;
Shintaro Kanda;
Hidehito Horinouchi;
Noboru Yamamoto;
Naomi Sakiyama;
Reiko Ando Makihara;
Yuichiro Ohe

Publication type:

Article

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 618, doi. 10.1093/jjco/hyx045

By:

Toyoaki Hida;
Miyako Satouchi;
Kazuhiko Nakagawa;
Takashi Seto;
Shingo Matsumoto;
Katsuyuki Kiura;
Hiroshi Nokihara;
Haruyasu Murakami;
Kota Tokushige;
Ben Hatano;
Makoto Nishio

Publication type:

Article